Literature DB >> 24010394

When to Order a Contrast-Enhanced CT.

James V Rawson1, Allen L Pelletier.   

Abstract

Family physicians often must determine the most appropriate diagnostic tests to order for their patients. It is essential to know the types of contrast agents, their risks, contraindications, and common clinical scenarios in which contrast-enhanced computed tomography is appropriate. Many types of contrast agents can be used in computed tomography: oral, intravenous, rectal, and intrathecal. The choice of contrast agent depends on route of administration, desired tissue differentiation, and suspected diagnosis. Possible contraindications for using intravenous contrast agents during computed tomography include a history of reactions to contrast agents, pregnancy, radioactive iodine treatment for thyroid disease, metformin use, and chronic or acutely worsening renal disease. The American College of Radiology Appropriateness Criteria is a useful online resource. Clear communication between the physician and radiologist is essential for obtaining the most appropriate study at the lowest cost and risk to the patient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010394

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

1.  Contrast Medium Use in Computed Tomography for Patients Presenting with Headache: 4-year Retrospective Two-Center Study in Central and Western Regions of Ghana.

Authors:  Bashiru Babatunde Jimah; Benjamin Dabo Sarkodie; Asare Kwaku Offei; Ewurama Andam Idun; Dorothea Anim; Edmund Brakohiapa; Benard Ohene Botwe
Journal:  Radiol Res Pract       Date:  2022-10-04

2.  Deep learning for cerebral angiography segmentation from non-contrast computed tomography.

Authors:  Michał Klimont; Agnieszka Oronowicz-Jaśkowiak; Mateusz Flieger; Jacek Rzeszutek; Robert Juszkat; Katarzyna Jończyk-Potoczna
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

3.  Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis.

Authors:  Chaan S Ng; Sanjeeva P Kalva; Candace Gunnarsson; Michael P Ryan; Erin R Baker; Ravindra L Mehta
Journal:  Cancer Imaging       Date:  2018-08-24       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.